Clinical Trials Logo

Clinical Trial Summary

Fifty-five patients received three subcutaneous heparin injections (165 injections) by the same investigator using additional techniques such as mechano-analgesia and cold application, and without any additional techniques.


Clinical Trial Description

The abdomen was divided into four quarters. The first, second, and third SC heparin injections were applied from the right abdominal region using ShotBlocker®, left abdominal region with an ice pack, and lower abdominal region without any additional application, respectively. All the injection sites were circled using a skin marking pen (r = 5 cm).

All the injections were administered following a standard procedure. Pain and satisfaction were assessed immediately after the injection by using the VAS score. Ecchymosis was assessed with an ecchymosis measurement tool at 48 and 60 hours after the injection (Figure 3). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03645369
Study type Interventional
Source Istanbul Saglik Bilimleri University
Contact
Status Completed
Phase N/A
Start date March 2, 2015
Completion date December 25, 2015

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06093815 - Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products N/A
Completed NCT05007041 - Simultaneous RZV and aIIV4 Vaccination Phase 4
Completed NCT05157230 - Evaluation of Deltoid Exercises on Injection Site Pain After (BNT162b2) COVID - 19 Vaccination N/A
Completed NCT05028361 - Simultaneous mRNA COVID-19 and IIV4 Vaccination Study Phase 4
Completed NCT03841396 - A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers. Phase 4
Recruiting NCT04962152 - Naldebain and Video-assisted Thoracoscopic Surgery Phase 4
Completed NCT03183908 - FLUAD® vs. Fluzone® High-Dose Study Phase 4
Recruiting NCT05221333 - Sorrel 25R Injector - Sorrel Clinical Study Protocol N/A
Completed NCT05157191 - Safety of Pediatric COVID-19 Vaccination